Equillium (EQ) Return on Sales (2023 - 2025)
Equillium (EQ) posted quarterly Return on Sales of 0.07% for Q3 2025, down 7.0% year-over-year from 0.07% in Q3 2024, and down 435.3% quarter-over-quarter from 0.01% in Q2 2025.
Equillium (EQ) Return on Sales (2023 - 2025) Analysis & Trends
Equillium (EQ) has reported Return on Sales for 3 consecutive years, with 0.07% the latest figure, recorded in Q3 2025.
- In Q3 2025, Return on Sales fell 7.0% year-over-year to 0.07%; the TTM figure through Sep 2025 stood at 0.07% (down 7.0% YoY), while the FY2024 annual figure was 0.0%, changed 0.0% from the prior year.
- Return on Sales declined to 0.07% in Q3 2025 per EQ's latest filing, from 0.01% in the prior quarter.
- Across five years, Return on Sales topped out at 0.0% in Q2 2024 and bottomed at 0.07% in Q3 2025.
- Historically, Return on Sales has averaged 0.01% across 3 years, with a median of 0.0% in 2023.
- Annual changes were most pronounced in 2024 — Return on Sales changed 0 bps — and 2025, when it fell 7 bps.
- Equillium's Return on Sales stood at 0.0% in 2023, then tumbled by 243 bps to 0.01% in 2024, then slumped by 405 bps to 0.07% in 2025.
- Business Quant data shows EQ's Return on Sales at 0.07% in Q3 2025, 0.01% in Q2 2025, and 0.0% in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 0.00% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.00% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.00% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.00% |
| 10 | Equillium | 263.86 Mn | 263.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -0.07% |
| Jun 30, 2025 | -0.01% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | -0.01% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |